Phase I trial of escalating doses of ABI-007 (nanoparticle albumin-bound paclitaxel) and gemcitabine in patients (pts) with thoracic malignancies
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2265690782
